NCT03971669View on ClinicalTrials.gov

Blood Donor CVD 5000

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 16, 2004

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Risk Reduction
Interventions
DRUG

Vivotif Typhoid Oral Vaccine

The 4 doses (1 capsule each) will be administered on alternate days, e.g., days 0, 2, 4, and 7 (± 1 day) under the supervision of the study coordinator(s).

Trial Locations (1)

21201

RECRUITING

University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER